Alphai.io Logo
Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent - Lisata Therapeutics ( NASDAQ:LSTA )